Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
about
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.T cell exhaustion: from pathophysiological basics to tumor immunotherapy.Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Interaction of molecular alterations with immune response in melanoma.Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM).BRAF inhibitors: resistance and the promise of combination treatments for melanoma.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?Dramatic response to nivolumab in xeroderma pigmentosum skin tumor.Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls.Emerging biomarkers for cancer immunotherapy in melanoma.Bringing the next Generation of Immuno-Oncology Biomarkers to the Clinic.Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.Mutation load estimation model as a predictor of the response to cancer immunotherapy.
P2860
Q33806351-030498FF-C5ED-4ABB-B068-CEDC647532C7Q39078341-BC4ABF83-4CF0-4D28-A95D-266B82DA5010Q39130451-5FA648B3-B7DF-43C5-B983-A22F5C8C405EQ39329609-43104B42-9D3A-4172-ADA6-814D2D23E3BFQ41475564-78C349C6-59F1-4C2C-BAD3-6EB46A10F742Q47101836-F4061800-C52C-455F-B029-E6F8DDEAC575Q47104481-0BDC801F-20DA-4F47-9704-EDFC5E4861C6Q47120629-49184D46-010C-4CC2-B20D-4E1339180A07Q47617121-8C83CF2E-8A1A-4A70-A526-C8F2359E0CE7Q47625086-654EB34C-2ACE-49A7-ACF3-91B1DC319993Q47862144-BEA9A707-3FBE-4CED-B256-C150BB018363Q50058145-8CD3ADED-BA67-4A46-BB83-65238FD0E4F4Q52385841-016961C0-1003-4699-800A-78CAD4FD2BDFQ53081522-09270D3B-33B4-42F0-8E4E-15DD0CAEE75AQ55261882-69BDA6B0-7FC3-4E77-95D5-80DA5F9D47F4
P2860
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel algorithmic approach pre ...... g a defined gene mutation set.
@ast
Novel algorithmic approach pre ...... g a defined gene mutation set.
@en
type
label
Novel algorithmic approach pre ...... g a defined gene mutation set.
@ast
Novel algorithmic approach pre ...... g a defined gene mutation set.
@en
prefLabel
Novel algorithmic approach pre ...... g a defined gene mutation set.
@ast
Novel algorithmic approach pre ...... g a defined gene mutation set.
@en
P2093
P2860
P50
P1433
P1476
Novel algorithmic approach pre ...... g a defined gene mutation set.
@en
P2093
Agda K Eterovic
Alan E Siroy
Alexander J Lazar
Aron Y Joon
Cara L Haymaker
Chantale Bernatchez
Don L Gibbons
Francesco C Stingo
Gordon B Mills
Jason Roszik
P2860
P2888
P356
10.1186/S12916-016-0705-4
P407
P577
2016-10-25T00:00:00Z
P6179
1051992805